Research graph
References from Comprehensive role of fluorine-18-labeled fluorodeoxyglucose PET/computed tomography across the disease course of primary malignant melanoma of the esophagus. Local targets link to admitted publications; unresolved targets remain external evidence.
Characteristics analyses and tumor staging proposal for primary malignant melanoma of the esophagus: a retrospective study.
10.1093/dote/doaf009 · 2025 · External reference
Clinical characteristics and treatment outcomes of primary malignant melanoma of esophagus: a single center experience.
10.1186/s12876-022-02235-8 · 2022 · External reference
Clinicopathological characterization of ten patients with primary malignant melanoma of the esophagus and literature review.
10.4251/wjgo.v14.i9.1739 · 2022 · External reference
The thousand faces of malignant melanoma: a systematic review of the primary malignant melanoma of the esophagus.
10.3390/cancers14153725 · 2022 · External reference
Primary malignant melanoma of the esophagus: a retrospective analysis of clinical features, management, and survival of 76 patients.
10.1111/1759-7714.13034 · 2019 · External reference
Diagnostic accuracy of (18)F-FDG-PET/CT in early and late stages of high-risk cutaneous malignant melanoma.
10.1111/jdv.13084 · 2015 · External reference
Rational use of (18)F-FDG PET/CT in patients with advanced cutaneous melanoma: a systematic review.
10.1016/j.critrevonc.2020.103044 · 2020 · External reference
Recommendations for pathologic staging (pTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals.
10.1111/dote.12533 · 2016 · External reference
Primary malignant melanoma of the esophagus: differentiation from esophageal squamous cell carcinoma and leiomyoma using dynamic contrast-enhanced CT findings.
10.1007/s00261-022-03556-8 · 2022 · External reference
Primary esophageal melanoma: report of a case.
10.17235/reed.2016.3908/2015 · 2016 · External reference
Characteristics and prognosis of primary malignant melanoma of the esophagus.
10.1097/md.0000000000020957 · 2020 · External reference
Results of surgical treatment for primary malignant melanoma of the esophagus: a multicenter retrospective study.
10.1016/j.jtcvs.2020.03.006 · 2021 · External reference
One-by-one comparison of lymph nodes between 18F-FDG uptake and pathological diagnosis in esophageal cancer.
10.1097/rlu.0000000000003224 · 2020 · External reference
Additional value of PET/CT over PET in assessment of locoregional lymph nodes in thoracic esophageal squamous cell cancer.
2006 · External reference
Primary malignant melanoma of the esophagus: a rare and aggressive disease.
10.1186/1477-7819-11-210 · 2013 · External reference
Diagnosis and surgical outcomes for primary malignant melanoma of the esophagus: a single-center experience.
10.1016/j.athoracsur.2013.04.072 · 2013 · External reference
PET-CT underestimates the true pathological extent of disease at lymphadenectomy for melanoma patients after systemic therapy.
10.1016/j.ejso.2023.06.002 · 2023 · External reference
Primary esophageal malignant melanoma successfully treated with anti-PD-1 antibody for retroperitoneal recurrence after esophagectomy: a case report.
10.1016/j.ijscr.2020.09.034 · 2020 · External reference
The value of 18F-FDG PET/CT for predicting or monitoring immunotherapy response in patients with metastatic melanoma: a systematic review and meta-analysis.
10.1007/s00259-020-04967-9 · 2021 · External reference
FDG PET/CT for tumoral and systemic immune response monitoring of advanced melanoma during first-line combination ipilimumab and nivolumab treatment.
10.1007/s00259-020-04815-w · 2020 · External reference
PET/CT scan and biopsy-driven approach for safe anti-PD-1 therapy discontinuation in patients with advanced melanoma.
10.1136/jitc-2021-002955 · 2021 · External reference
Longitudinal genomic alternations and clonal dynamics analysis of primary malignant melanoma of the esophagus.
10.1016/j.neo.2022.100811 · 2022 · External reference
Primary malignant melanoma of the esophagus: a study of clinical features, pathology, management and prognosis.
10.1111/j.1442-2050.2010.01111.x · 2011 · External reference
Difficulties encountered in the diagnosis of primary esophageal malignant melanoma by 18F-fluorodeoxyglucose positron emission tomography/computed tomography: a case report.
10.21037/apm-21-649 · 2021 · External reference
Malignant melanoma of gastrointestinal tract on 18F-FDG PET/CT: three case reports.
2023 · External reference
18F-FDG PET/CT imaging of primary malignant melanoma of rectum with liver metastases mimicking rectum cancer: case report and literature review.
2022 · External reference
Evidence of 18F-FDG utility in rare case of metastatic anal melanoma with prolonged survival.
10.1097/rlu.0000000000005551 · 2025 · External reference
The diagnostic accuracy and clinical impact of FDG-PET/CT follow-up for patients on adjuvant immunotherapy for high-risk malignant melanoma.
10.1007/s00259-022-05704-0 · 2022 · External reference
Routine PET-CT scans provide early and accurate recurrence detection in asymptomatic stage IIB-III melanoma patients.
10.1016/j.ejso.2021.06.011 · 2021 · External reference
Impact of 18F-FDG-PET/CT on surgical management in patients with advanced melanoma: an outcome based analysis.
10.1007/s00259-017-3674-8 · 2017 · External reference
Pitfalls in evaluating FDG-PET/CT results in melanoma patients - A case series.
2023 · External reference
Melanin-targeted PET imaging with 18F-PFPN for identifying gastric metastatic melanoma.
10.1097/rlu.0000000000004237 · 2022 · External reference
